Artificial Intelligence (AI) Cytopathology Trial

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

July 21, 2021

Primary Completion Date

July 31, 2024

Study Completion Date

January 30, 2028

Conditions
Pancreatic Solid Lesions
Interventions
OTHER

Artificial Intelligence software ROSE

Rapid on-site evaluation (ROSE) of Endoscopic Ultrasound (EUS) guided FNA/FNB (Fine Needle Aspirate/Fine Needle Biopsy) of pancreatic solid lesions (PSLs) has been shown in improve diagnostic yield. The availability and performance of ROSE at EUS performing centers is variable. With strides in Artificial Intelligence (AI) capabilities over the years, the University of Texas at Health Sciences Center at Houston in collaboration with Haystac is developing an artificial intelligence based proprietary system to analyze slides from EUS FNA/FNB samples at bedside.

Trial Locations (1)

77030

RECRUITING

Memorial Hermann Hospital, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER